IFN-γ, in synergy with TNF-α, inhibits IEC proliferation and promotes apoptosis to sustain intestinal inflammation by inhibiting the Wnt-β-catenin signaling pathway [46] to contribute to the pathology of IBD. Here, TNF is linked to inflammatory bowel disease.